| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Fengming Zhu CEO | XSHE Exchange | CNE1000032C9 ISIN |
| CN Country | 933 Employees | 22 Jul 2026 Last Dividend | 22 Jul 2026 Last Split | - IPO Date |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is a prominent entity in the Chinese pharmaceutical industry, dedicated to the research, development, production, and sale of Chinese patent medicines within China. Established in 1997 and headquartered in Xi'an, China, the company has carved a niche for itself by specializing in a wide range of therapeutic areas, catering to the health needs of various patient demographics.
The product portfolio of Shaanxi Panlong Pharmaceutical Group is extensive and diverse, targeting multiple therapeutic areas and health concerns. Here are some of the key categories along with an explanation for each: